Apophysomyces Variabilis Infection in Transplant Recipients due to Unrecognized Infection in an Intravenous Drug-Using Donor

Transplantation. 2022 Feb 1;106(2):e169-e171. doi: 10.1097/TP.0000000000003921.

Peter Boan^{1

2}, Stanley Pang^{2

3}, Shakeel Mowlaboccus^{2

3}, Jeremy P Wrobel^{4

5}, Michael Musk⁴, Melanie Lavender⁴, Meow Cheong Yaw⁴, Adrian Hernest⁴, Gerry MacQuillan^{6

7}, Lawrence G Dembo⁸, Geoffrey W Coombs^{2

3}, Dianne J Gardam², Lynette A Pereira^{1

2}, J Owen Robinson^{1

2

3

9}

¹ Department of Infectious Diseases, Fiona Stanley Hospital, Perth, WA, Australia.
² Department of Microbiology, PathWest Laboratory Medicine WA, Fiona Stanley Hospital, Perth, WA, Australia.
³ College of Science, Health, Engineering and Education, Murdoch University, Perth, WA, Australia.
⁴ Advanced Lung Disease Unit, Fiona Stanley Hospital, Perth, WA, Australia.
⁵ Department of Medicine, University of Notre Dame Australia, Perth, WA, Australia.
⁶ Western Australian Liver Transplantation Service, Sir Charles Gairdner Hospital, Perth, WA, Australia.
⁷ School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia.
⁸ Advanced Heart Failure and Cardiac Transplant Service, Fiona Stanley Hospital, Perth, WA, Australia.
⁹ Department of Infectious Diseases, Royal Perth Hospital, Perth, WA, Australia.

No abstract available

MeSH terms